COMMUNIQUÉS West-GlobeNewswire

AVITA Medical to Host Investor Webinar Briefing
13/02/2026
VALENCIA, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective [...]
Solana Company (NASDAQ: HSDT) Becomes First Digital Asset Treasury to Enable Borrowing Against Natively Staked SOL in Qualified Custody
13/02/2026
Solana Company (HSDT), Anchorage Digital, and Kamino collaborate to bring institutional capital to Solana's high-performance DeFi ecosystem through a first-of-its-kind tri-party custody model Institutions earn staking [...]
Precision Optics Schedules Second Quarter of Fiscal Year 2026 Conference Call for February 17, 2026
13/02/2026
GARDNER, Mass., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]
Valneva fait un point sur l’utilisation du vaccin IXCHIQ® au Royaume-Uni
13/02/2026
Lyon (France), le 13 février 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui qu’à la suite d’une revue des bénéfices et risques du vaccin contre le [...]
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
13/02/2026
Lyon (France), February 13, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that following a review of the benefits and risks of the Company’s single‑dose chikungunya [...]
Sienna Announces February Dividend
13/02/2026
MARKHAM, Ontario, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune
13/02/2026
HCW Biologics receiving cash fee and co-founder shares in Trimmune valued at $7.0 million Trimmune will hold exclusive worldwide license for rights to high potential preclinical molecule created with HCW Biologics’ TRBC [...]
vTv Therapeutics to Participate in Upcoming Investor Conferences
13/02/2026
HIGH POINT, N.C., Feb. 13, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin , a novel, potential first-in-class oral [...]
Moleculin Launches CEO Corner Platform to Share Strategic Insights
13/02/2026
CEO Corner segments intended to provide added perspective to press releases, clinical trial developments and pipeline progress Provides interested parties with the ability to connect with the Company by submitting [...]
Netramark Announces Uplisting to Toronto Stock Exchange
13/02/2026
TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a company focused on AI-driven clinical trial optimization and precision [...]
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/02/2026
SAN DIEGO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate [...]
Opus Genetics Announces $25 Million Private Placement
13/02/2026
RESEARCH TRIANGLE PARK, N.C., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc . (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore [...]
Nephros Expands into Puerto Rico to Deliver Differentiated Water Filtration Solutions Across Medical and Commercial Sectors
13/02/2026
SOUTH ORANGE, N.J., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced its entry into [...]
Lyv Launches in the UK to Support The 500,000 Patients Going Private for Weight Loss Treatment
13/02/2026
Online pharmacy enters booming weight loss market with end to end patient care model as private prescriptions surge LONDON, Feb. 13, 2026 (GLOBE NEWSWIRE) -- A UK online pharmacy has entered the rapidly expanding weight [...]
Nasus Pharma Announces Closing of $15.0 Million Private Placement
13/02/2026
TEL AVIV, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today [...]
Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
13/02/2026
Increased revenue by 105% year-over-year (YoY) to $2.2 million in fiscal Q3 Maintain fiscal year 2026 revenue guidance of $8-10 million $22.3 million pro forma cash, cash equivalents, restricted cash and marketable [...]
HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights
13/02/2026
- Cash position of US$195 million as of December 31, 2025, before adjustment for post quarter events - - Topline data readout from the Phase 2 study evaluating HLP004 in generalized anxiety disorder (“GAD”) expected in [...]
Medicenna Announces Changes to Board Composition
13/02/2026
TORONTO and HOUSTON, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of [...]
Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
13/02/2026
Medicenna to present updated internal and external data sets related to bizaxofusp (MDNA55) at the 7th Annual Glioblastoma Development Summit to be held in Boston from 17-19 February 2026 Updated ABILITY-1 clinical data [...]

Pages